ECONOMIST & AUTHOR
Economist Ian Fletcher is one of America’s foremost experts on the problems of free trade. He is the author of Free Trade Doesn’t Work and the coauthor of The Conservative Case Against Free Trade and Industrial Policy for the United States.
He has been senior economist at the Coalition, a research fellow at the US Business and Industry Council, an economist in private practice, and an IT consultant. He was educated at Columbia University and the University of Chicago. He lives in San Francisco.
CPA Speakers Bureau Member: Ian Fletcher is available to speak to the topics of:
The Committee on Foreign Investment in the United States (CFIUS) turns 50 years old this year, and it still has lots to learn. The main disruptor – China – has ultimately added new layers to CFIUS oversight, but this oversight is in its infancy.
U.S. drugmakers are rapidly shifting the front end of America’s pharmaceutical ecosystem (e.g. discovery, early-stage-development, and the IP engine) to China through a surge of licensing deals and cross-border partnerships.
CPA this week applauded the acquisition of Nivagen Pharmaceuticals by member company, PAI Pharma (PAI), of Greenville, SC and Sacramento, CA.
AGOA, first enacted in 2000, provides qualifying sub-Saharan African nations with tariff-free access to the U.S. market for thousands of products and was intended to support economic development, democratic reform, and stronger geopolitical ties to the United States.
